 place isradipine treatment hypertension Isradipine new dihydropyridine calcium antagonist high degree selectivity coronary cerebral skeletal muscle vasculature drug minimal depressant activity sinoatrial node automaticity negligible negative chronotropic dromotropic inotropic actions Isradipine blood pressure systemic vascular resistance changes cardiac output stroke volume Renal blood flow renal vascular resistance short- long-term diuretic natriuretic effects Doses mg daily lowers blood pressure open placebo-controlled trials mg isradipine safe systolic diastolic values patients mild-to-moderate hypertension Efficacy similar nifedipine nitrendipine superior propranolol atenolol prazosin hydrochlorothiazide diltiazem drug beta-blockers angiotensin-converting enzyme ACE inhibitors diuretics Adverse effects dose-dependent secondary arterial vasodilatation headache flushing ankle edema dizziness palpitations tachycardia recommended dose mg total incidence side effects placebo antiatherosclerotic antitrophic cerebroprotective effects experimental animal models drug treatment human hypertension Isradipine blood pressure risk consequences peril cerebral stroke myocardial infarction